CDKN2A and Hepatic fibrosis: Moreover, resveratrol (RSV) has been shown to counteract arsenic-induced hepatocyte senescence by restoring SIRT1’s inhibitory effect on p16, thus suppressing SASP-related protein release, reducing fibrotic phenotypes and mitigating liver fibrosis (Ran et al., 2024).